Brain Biomarkers | Mild-Mod COVID Treatments

26/07/2025 10 min Temporada 5 Episodio 30
Brain Biomarkers | Mild-Mod COVID Treatments

Listen "Brain Biomarkers | Mild-Mod COVID Treatments"

Episode Synopsis

The JournalFeed podcast for the week of July 21-25, 2025.These are summaries from just 2 of the 5 articles we cover every week! For access to more, please visit JournalFeed.org for details about becoming a member.Monday Spoon Feed:Novel blood-based biomarkers, specifically GFAP, UCH-L1, S100B, and NfL, may be well suited for early classification and triage of patients with acute and subacute minor traumatic brain injury.Tuesday Spoon Feed:To reduce hospitalizations of patients with mild to moderate COVID, treat with nirmatrelvir-ritonavir (Paxlovid) or remdesivir. To shorten the duration of COVID symptoms, azithroycin, favipiravir, molnupiravir, umifenovir, or corticosteroids may help, but they are not standard of care.